This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miyazu, Y. M. Articles by Hiyama, E. Search for Related Content PubMed PubMed Citation Articles by Miyazu, Y. M. Articles by Hiyama, E.

Telomerase Expression in Noncancerous Bronchial Epithelia Is a Possible Marker of Early Development of Lung Cancer

Departments of ¹ Pulmonary Medicine and ² Pathology, Hiroshima City Hospital; ³ Department of Translational Cancer Research, Research Institute for Radiation Biology and Medicine Hiroshima University; ⁴ Department of Surgery, Hiroshima National Hospital; ⁵ Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences; and ⁶ Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan; and Departments of ⁷ Respiratory and Infectious Diseases and ⁸ Surgery, St. Marianna University School of Medicine, Kawasaki, Japan

Requests for reprints: Eiso Hiyama, Natural Science Center for Basic Research and Development, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551 Japan. Phone: 81-82-257-5951; Fax: 81-82-257-5219; E-mail: eiso{at}hiroshima-u.ac.jp.

Centrally located lung cancers in smokers frequently associated with subsequent primary tumors. We evaluated the telomerase expression chronologically in noncancerous epithelia as a risk factor of susceptibility to lung cancer development. Telomerase protein expression was examined in situ by immunohistochemistry in 26 noncancerous bronchial epithelia adjacent to centrally located early-stage lung cancers in sequential 23 patients treated by photodynamic therapy or surgery among 206 patients who underwent autofluorescence bronchoscopy from 1997 to 2003. Among the 15 lesions in 12 patients treated by photodynamic therapy alone, 11 lesions achieved complete remission after photodynamic therapy, and none of their noncancerous bronchial epithelia was telomerase positive. On the contrary, in the remaining four lesions, either recurrence or secondary lung cancer developed adjacent to the successfully treated primary cancer within 26 months, and the telomerase protein expression in noncancerous epithelia was detected before the secondary cancer development (P < 0.001). The overall relationship of human telomerase reverse transcriptase positivity in noncancerous epithelia and subsequent lung cancer development, including patients treated by radiation or surgery, showed higher significance (P < 0.0001). Histologically "normal" bronchial epithelia in smokers may unphysiologically express telomerase as a field, and such epithelia are likely susceptible to develop lung cancer. We propose that ectopic expression of telomerase in bronchial epithelia may precede transformation in human lung cancer development and that detection of telomerase protein in noncancerous bronchial epithelia will become a useful marker detecting high-risk patients for lung cancer development.

This article has been cited by other articles:

				K. Steiling, J. Ryan, J. S. Brody, and A. Spira The Field of Tissue Injury in the Lung and Airway Cancer Prevention Research, November 1, 2008; 1(6): 396 - 403. [Abstract] [Full Text] [PDF]

				D. Sidransky The Oral Cavity as a Molecular Mirror of Lung Carcinogenesis Cancer Prevention Research, June 1, 2008; 1(1): 12 - 14. [Full Text] [PDF]